Angiotensin II AT1 Receptor Blockade Ameliorates Brain Inflammation

Benicky, Julius, Sánchez-Lemus, Enrique, Honda, Masaru, Pang, Tao, Orecna, Martina, Wang, Juan, Leng, Yan, Chuang, De-Maw +1 more·2011·Neuropsychopharmacology

Cited by (254)

Items 101–200 of 254

  1. Antimanic-like activity of candesartan in mice: Possible involvement of antioxidant, anti-inflammatory and neurotrophic mechanisms
    Júlia Ariana de Souza Gomes, Greicy Coelho de Souza, Michael Berk, Lígia Menezes Cavalcante, Francisca Cléa Florenço de Sousa, Josiane Budni, David Freitas de Lucena, João Quevedo, Andre Ferrer Carvalho, Danielle S. Macêdo · 2015 · European Neuropsychopharmacology
  2. Telmisartan Protects a Microglia Cell Line from LPS Injury Beyond AT1 Receptor Blockade or PPARγ Activation
    ABDEL G. ELKAHLOUN, Yara Rodríguez, Seham Alaiyed, Erin D. Wenzel, Juan M. Saavedra · 2018 · Molecular Neurobiology
  3. Targeting the renin angiotensin system for the treatment of anxiety and depression
    Sophocles Chrissobolis, Anh N. Luu, Ryan A. Waldschmidt, Madison E. Yoakum, Manoranjan S. D’Souza · 2020 · Pharmacology Biochemistry and Behavior
  4. Cardiovascular therapeutics: A new potential for anxiety treatment?
    Kristina Repova, Silvia Aziriova, Kristina Krajcirovicova, Fedor Šimko · 2022 · Medicinal Research Reviews
  5. Angiotensin‐converting enzymes as druggable features of psychiatric and neurodegenerative disorders
    T. C. Santiago, L. Parra, J. Nani, T. Fidalgo, N. Bradshaw, M. Hayashi · 2023 · Journal of Neurochemistry
  6. The Role of Angiotensin II/AT1 Receptor Signaling in Regulating Retinal Microglial Activation
    Joanna A. Phipps, Kirstan A. Vessey, Alice A. Brandli, Nupur Nag, Mai X. Tran, Andrew Ian Jobling, Erica Lucy Fletcher · 2018 · Investigative Ophthalmology & Visual Science
  7. High Blood Pressure Effects on the Blood to Cerebrospinal Fluid Barrier and Cerebrospinal Fluid Protein Composition: A Two‐Dimensional Electrophoresis Study in Spontaneously Hypertensive Rats
    Ibrahim González-Marrero, Leandro Castañeyra-Ruiz, Juan M. González-Toledo, Agustín Castañeyra-Ruiz, Héctor de Paz-Carmona, Rafael Castro, Juan Ramon Hernandez-Fernaud, Agustín Castañeyra-Perdomo, Emilia M. Carmona-Calero · 2013 · International Journal of Hypertension
  8. Involvement of the Renin-Angiotensin System in Stress: State of the Art and Research Perspectives
    Bernardo Henrique Mendes Correa, Luca Becari, Marco Antônio Peliky Fontes, Ana Cristina Simões e Silva, Lucas Miranda Kangussu · 2021 · Current Neuropharmacology
  9. Anti-inflammatory effects of fimasartan via Akt, ERK, and NFκB pathways on astrocytes stimulated by hemolysate
    Xiu-Li Yang, Chi Kyung Kim, Tae Jung Kim, Jing Sun, Doeun Rim, Young Ju Kim, Sang‐Bae Ko, Hyunduk Jang, Byung‐Woo Yoon · 2015 · Inflammation Research
  10. Correlation between angiotensin 1–7-mediated Mas receptor expression with motor improvement, activated STAT3/SOCS3 cascade, and suppressed HMGB-1/RAGE/NF-κB signaling in 6-hydroxydopamine hemiparkinsonian rats
    Mostafa Adel Rabie, Mai A. Abd El Fattah, Noha Nagah Nassar, Dalaal M. Abdallah, Hanan Salah El-Abhar · 2019 · Biochemical Pharmacology
  11. Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's disease.
    Edward C. Lauterbach · 2016 · Europe PMC (PubMed Central)
  12. Genetic Variants of Angiotensin-Converting Enzyme Are Linked to Autism: A Case-Control Study
    Negar Firouzabadi, Nima Ghazanfari, Ali Alavi Shoushtari, Nasrollah Erfani, Farshid Fathi, Mozhdeh Bazrafkan, Ehsan Bahramali · 2016 · PLoS ONE
  13. The skeletal renin-angiotensin system: A potential therapeutic target for the treatment of osteoarticular diseases
    Jingjing Zhao, Hao Yang, Bo Chen, Rui Zhang · 2019 · International Immunopharmacology
  14. Transcriptomic Analysis of Mouse Brain After Traumatic Brain Injury Reveals That the Angiotensin Receptor Blocker Candesartan Acts Through Novel Pathways
    Peter J. Attilio, Dustin M. Snapper, Milan Rusnak, Akira J. Isaac, Anthony R. Soltis, Matthew D. Wilkerson, Clifton L. Dalgard, Aviva J. Symes · 2021 · Frontiers in Neuroscience
  15. Molecular signaling pathways underlying schizophrenia
    Jari Tiihonen, Marja Koskuvi, Markku Lähteenvuo, Kalevi Trontti, Ilkka Ojansuu, Olli Vaurio, Tyrone D. Cannon, Jouko K Lönnqvist, Sebastian Therman, Jaana Suvisaari et al. · 2021 · Schizophrenia Research
  16. Multiple Aspects of Inappropriate Action of Renin–Angiotensin, Vasopressin, and Oxytocin Systems in Neuropsychiatric and Neurodegenerative Diseases
    Ewa Krystyna Szczepanska‐Sadowska, Agnieszka Wsół, Agnieszka Cudnoch‐Jędrzejewska, Katarzyna Czarzasta, Tymoteusz Żera · 2022 · Journal of Clinical Medicine
  17. Immunomodulatory Effects of RAAS Inhibitors: Beyond Hypertension and Heart Failure
    Raluca Ecaterina Haliga, Elena Cojocaru, Oana Sîrbu, Ilinca Hrițcu, Raluca-Elena Alexa, Ioana Bianca Haliga, Victorița Șorodoc, Adorata Elena Coman · 2025 · Biomedicines
  18. Food Enrichment with Glycyrrhiza glabra Extract Suppresses ACE2 mRNA and Protein Expression in Rats—Possible Implications for COVID-19
    Daniela Ježová, Peter Karailiev, Lucia Karailievova, Agnesa Puhova, Harald Murck · 2021 · Nutrients
  19. Manifestation of renin angiotensin system modulation in traumatic brain injury
    Golnoush Mirzahosseini, Saifudeen Ismael, Heba A. Ahmed, Tauheed Ishrat · 2021 · Metabolic Brain Disease
  20. Inhibition of angiotension II type 1 receptor reduced human endothelial inflammation induced by low shear stress
    Yuelin Chao, Linlin Zhu, Xinliang Qu, Junxia Zhang, Junjie Zhang, Xiangquan Kong, Yue Gu, Jiangqin Pu, Wen Wu, Peng Ye et al. · 2017 · Experimental Cell Research
  21. The renin–angiotensin–aldosterone system: Role in pathogenesis and potential therapeutic target in COVID‐19
    Cássia Lisboa Braga, Rodrigo Pacheco Silva-Aguiar, Denise Battaglini, Diogo B. Peruchetti, Chiara Robba, Paolo P. Pelosi, Patrícia R. M. Rocco, Celso Caruso‐Neves, Pedro Leme Silva · 2020 · Pharmacology Research & Perspectives
  22. Expression of integrin and CD 44 receptors recognising osteopontin in the normal and LPS ‐lesioned rat substantia nigra
    Sara Ailane, Philip Long, Peter G. Jenner, Sarah Rose · 2013 · European Journal of Neuroscience
  23. Conventional cardiovascular risk factors in Transient Global Amnesia: Systematic review and proposition of a novel hypothesis
    Ioannis Liampas, Maria Raptopoulou, Vasileios Siokas, Christos Bakirtzis, Zisis Tsouris, Athina‐Maria Aloizou, Metaxia Dastamani, Alexandros G. Brotis, Dimitrios Petrou Bogdanos, Efthimios Dardiotis · 2021 · Frontiers in Neuroendocrinology
  24. Angiotensin II receptor blocker or angiotensin-converting enzyme inhibitor use and COVID-19-related outcomes among US Veterans
    Catherine G. Derington, Jordana B. Cohen, April F. Mohanty, Tom Greene, James R. Cook, Jian Ying, Guo Wei, Jennifer S. Herrick, Vanessa W Stevens, Barbara Ellen Jones et al. · 2021 · PLoS ONE
  25. Losartan Treatment Could Improve the Outcome of TBI Mice
    Jianhua Xiong, Yalong Gao, Xiaotian Li, Kai Li, Qifeng Li, Jun Shen, Zhenying Han, Jianning Zhang · 2020 · Frontiers in Neurology
  26. The Protective Arms of the Renin-Angiontensin System in Stroke
    Claudia A. McCarthy, Lachlan J. Facey, Robert E. Widdop · 2014 · Current Hypertension Reports
  27. Synthetic PPAR Agonist DTMB Alleviates Alzheimer's Disease Pathology by Inhibition of Chronic Microglial Inflammation in 5xFAD Mice
    Eun-Ji Oh, Jeong-hwa Kang, Kyung Won Jo, Won-Sik Shin, Young-Hun Jeong, Byunghee Kang, Tae-Young Rho, So Yeon Jeon, Jihoon Lee, Im‐Sook Song et al. · 2022 · Neurotherapeutics
  28. The Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril and the Angiotensin II Type 1 Receptor Blocker Losartan on Fracture Healing in Rats
    Ahmet Bayar, Ali Turan, Kanat Gülle, Meryem Akpolat, İnci TURAN, Egemen Turhan · 2015 · Clinical and investigative medicine
  29. Central nervous system circuits modified in heart failure: pathophysiology and therapeutic implications
    Bernardo Sousa‐Pinto, Manuel J. Ferreira‐Pinto, Mário Santos, Adelino Ferreira Leite-Moreira · 2014 · Heart Failure Reviews
  30. Neuroinflammation in Pulmonary Hypertension: Concept, Facts, and Relevance
    Aline M. Hilzendeger, Vinayak Shenoy, Mohan K. Raizada, Michael J. Katovich · 2014 · Current Hypertension Reports
  31. Angiotensin II AT1 receptor blocker candesartan prevents the fast up-regulation of cerebrocortical benzodiazepine-1 receptors induced by acute inflammatory and restraint stress
    Enrique Sánchez-Lemus, Masaru Honda, Juan M. Saavedra · 2012 · Behavioural Brain Research
  32. Chronic high dose of captopril induces depressive-like behaviors in mice: possible mechanism of regulatory T cell in depression
    Hyun-Sun Park, Arum Han, Hye-Lim Yeo, Min-Jung Park, Min‐Jung You, Hyun Jin Choi, Chang-Won Hong, Sang‐Hyuk Lee, Seung Hyun Kim, Borah Kim et al. · 2017 · Oncotarget
  33. Depression as an Immunometabolic Disorder: Exploring Shared Pharmacotherapeutics with Cardiovascular Disease
    Mervin Chávez-Castillo, Manuel Nava, Ángel Ortega, Milagros Rojas, Victoria Núñez, Juan José Salazar, Valmore Bermúdez, Joselyn Rojas · 2020 · Current Neuropharmacology
  34. The central renin–angiotensin system: A genetic pathway, functional decoding, and selective target engagement characterization in humans
    Ting Xu, Zhiyi Chen, Xinqi Zhou, Lan Wang, Feng Zhou, Dezhong Yao, Bo Zhou, Benjamin Becker · 2024 · Proceedings of the National Academy of Sciences
  35. A comparative study on the anti-inflammatory effect of angiotensin-receptor blockers & statins on rheumatoid arthritis disease activity
    Tarek M. Mostafa, Sahar Kamal Hegazy, Emad M. El-Shebiny, Dalia S. Saif, Ahmed H Elabd · 2020 · The Indian Journal of Medical Research
  36. Losartan improved hippocampal long‐term potentiation impairment induced by repeated LPS injection in rats
    M. Hosseini, H. Salmani, Y. Baghcheghi · 2021 · Physiological Reports
  37. Angiotensin-(1–7) Via the Mas Receptor Alleviates the Diabetes-Induced Decrease in GFAP and GAP-43 Immunoreactivity with Concomitant Reduction in the COX-2 in Hippocampal Formation: An Immunohistochemical Study
    Waleed M. Renno, Anwar G. Al-Banaw, Preethi George, Asmaa A. Abu-Ghefreh, Saghir Akhtar, Ibrahim F. Benter · 2012 · Cellular and Molecular Neurobiology
  38. The Effect of Candesartan Alone and Its Combination With Estrogen on Post-traumatic Brain Injury Outcomes in Female Rats
    Mojdeh Hajmohammadi, Mohammad Khaksari, Zahra Soltani, Nader Shahrokhi, Hamid Najafipour, Reza Abbasi · 2019 · Frontiers in Neuroscience
  39. Validation of Brain Angiotensin System Blockade as a Novel Drug Target in Pharmacological Treatment of Neuropsychiatric Disorders
    Dominik Wincewicz, Jan Józef Braszko · 2017 · Pharmacopsychiatry
  40. Candesartan Neuroprotection in Rat Primary Neurons Negatively Correlates with Aging and Senescence: a Transcriptomic Analysis
    ABDEL G. ELKAHLOUN, Juan M. Saavedra · 2019 · Molecular Neurobiology
  41. Angiotensin 1 receptor antagonist attenuates acute kidney injury-induced cognitive impairment and synaptic plasticity via modulating hippocampal oxidative stress
    Fatemeh Sharifi, Parham Reisi, Maryam Malek · 2019 · Life Sciences
  42. Effect of Long-Term Treatment with Fimasartan on Transient Focal Ischemia in Rat Brain
    Chi Kyung Kim, Xiu-Li Yang, Young Ju Kim, In-Young Choi, Han‐Gil Jeong, Hong‐Kyun Park, Dohoung Kim, Tae Jung Kim, Hyunduk Jang, Sang‐Bae Ko et al. · 2015 · BioMed Research International
  43. Curative Effect of AD-MSCs against Cisplatin-Induced Hepatotoxicity in Rats is Potentiated by Azilsartan: Targeting Oxidative Stress, MAPK, and Apoptosis Signaling Pathways
    Amany Abdlrehim Bekhit, Olivia N. Beshay, Michael Atef Fawzy, Sara Mohamed Naguib Abdel Hafez, Gaber El‐Saber Batiha, Farid Shokry Ataya, Moustafa Fathy · 2023 · Stem Cells International
  44. Expanding telmisartan’s therapeutic horizon: exploring its multifaceted mechanisms beyond cardiovascular disorders
    Yogesh Suresh Ahire, Vinod Ashok Bairagi, Deepak Somavanshi, Smruti R. Jadhav, Swapnil B. Jadhav, Shekhar D. Jagtap · 2024 · Future Journal of Pharmaceutical Sciences
  45. Angiotensin receptor blocker use is associated with upregulation of the memory-protective angiotensin type 4 receptor (AT4R) in the postmortem brains of individuals without cognitive impairment
    Çağlar Coşarderelioğlu, Lolita S. Nidadavolu, Claudene J. George, Ruth Marx-Rattner, Laura Powell, Qian‐Li Xue, Jing Tian, Esther S. Oh, Luigi Ferrucci, Pervin Dinçer et al. · 2022 · GeroScience
  46. Neurovascular unit alteration in somatosensory cortex and enhancement of thermal nociception induced by amphetamine involves central AT 1 receptor activation
    Victoria Belén Occhieppo, Natalia Andrea Marchese, Iara Diamela Rodríguez, Osvaldo Martín Basmadjian, Gustavo Baiardi, Claudia Bregonzio · 2017 · European Journal of Neuroscience
  47. Angiotensin-II drives changes in microglia–vascular interactions in rats with heart failure
    Ferdinand Althammer, Ranjan K. Roy, Matthew K. Kirchner, Yuval Podpecan, Jemima Helen, Shaina McGrath, Elba Campos‐Lira, Javier Eduardo Stern · 2024 · Communications Biology
  48. A hydrogel-based nanoparticles sustained-release system selectively targeting pro-inflammatory microglia for spinal cord injury repair
    Wanrong Ma, Yijie Kong, Xiaolong Sheng, Ting Liu, Kai Zhang, Runlin Wen, Dingyang Liu, Ge Long, Xing Li · 2025 · Journal of Controlled Release
  49. Losartan treatment attenuates the development of neuropathic thermal hyperalgesia induced by peripheral nerve injury in rats
    Nataliia Kalynovska, Mickaël Diallo, Jiřı́ Paleček · 2019 · Life Sciences
  50. The application of telmisartan in central nervous system disorders
    Wei Quan, Shui-Xian Zhang, Xu-Yang Zhang, Xi Chen, Chao Yang, Zhiyu Li, Rong Hu · 2025 · Pharmacological Reports
  51. Candesartan restores blood–brain barrier dysfunction, mitigates aberrant gene expression, and extends lifespan in a knockin mouse model of epileptogenesis
    Michael F. Hammer, Erfan Bahramnejad, Joseph C. Watkins, Patrick T. Ronaldson · 2024 · Clinical Science
  52. Telmisartan Inhibits TNFα-Induced Leukocyte Adhesion by Blocking ICAM-1 Expression in Astroglial Cells but Not in Endothelial Cells
    Changhwan Jang, Jungjin Kim, Youngsun Kwon, Sangmee Ahn Jo · 2020 · Biomolecules & Therapeutics
  53. Microglial activation induced by LPS mediates excitation of neurons in the hypothalamic paraventricular nucleus projecting to the rostral ventrolateral medulla
    Tae Hee Han, Heow Won Lee, Eun A Kang, Min Seok Song, So Yeong Lee, Pan Dong Ryu · 2021 · BMB Reports
  54. A data-driven modeling approach to identify disease-specific multi-organ networks driving physiological dysregulation
    Warren D. Anderson, Danielle DeCicco, James S. Schwaber, Rajanikanth Vadigepalli · 2017 · PLoS Computational Biology
  55. A Review on Neuroinflammatory Pathway Mediating Through Ang-II/AT1 Receptors and a Novel Approach for the Treatment of Cerebral Ischemia in Combination with ARB’s and Ceftriaxone
    Gaddam Narasimha Rao, Srikanth Jupudi, Antony Justin · 2023 · Annals of Neurosciences
  56. An Open‐Label, Non‐randomized, Drug‐Repurposing Study to Explore the Clinical Effects of Angiotensin II Type 1 ( AT1 ) Receptor Antagonists on Anxiety and Depression in Parkinson's Disease
    Sofía Bordet, Lina Grasso, Lucas Udovin, Guenson Chevalier, Matilde E. Otero Losada, Francisco Capani, Santiago Perez‐Lloret · 2025 · Movement Disorders Clinical Practice
  57. Different protective and reparative effects of olmesartan in stroke according to time of administration and withdrawal
    María Gutiérrez‐Fernández, Blanca Fuentes, Berta Rodríguez‐Frutos, Jaime Ramos‐Cejudo, Laura Otero‐Ortega, Exuperio Díez‐Tejedor · 2014 · Journal of Neuroscience Research
  58. Brain perivascular macrophages: connecting inflammation to autonomic activity in hypertension
    Sébastien Foulquier · 2019 · Hypertension Research
  59. Neuroprotective mechanism of losartan and its interaction with nimesulide against chronic fatigue stress
    Anil Kumar, Barinder Singh, Jitendriya Mishra, Sangeeta Pilkhwal Sah, Raghavender Pottabathini · 2015 · Inflammopharmacology
  60. Receptors on Microglia
    Marcus Augusto‐Oliveira, Marie‐Ève Tremblay, Alexei Verkhratsky · 2024 · Advances in neurobiology
  61. Mitigation of radiation myelopathy and reduction of microglial infiltration by Ramipril, ACE inhibitor
    Mariano Guardia Clausi, Alexander Michael Stessin, Stella E. Tsirka, Samuel Ryu · 2018 · Spinal Cord
  62. Systemic Candesartan Treatment Modulates Behavior, Synaptic Protein Levels, and Neuroinflammation in Female Mice That Express Human APOE4
    Sarah B. Scheinman, Steve Zaldua, Adedoyin Dada, Kateryna Krochmaliuk, Katherine Dye, Felecia M. Marottoli, Gregory R. J. Thatcher, Leon M. Tai · 2021 · Frontiers in Neuroscience
  63. Effect of prorenin peptide vaccine on the early phase of diabetic retinopathy in a murine model of type 2 diabetes
    Harumasa Yokota, Hiroki Hayashi, Junya Hanaguri, Satoru Yamagami, Akifumi Kushiyama, Hironori Nakagami A, Taiji Nagaoka · 2022 · PLoS ONE
  64. Current updates on latest basic research of scientific relevance in hypertensive dementia
    Masaki Mogi, Yoichi Takami, Masafumi Ihara, Toru Yamashita, Shuko Takeda, Shigeru Shibata, Kouichi Node, Kazuomi Kario, Prevention of Cognitive Impairment by Hypertension Management (PCIHM) Working Group of the Japanese Society of Hypertension, Masaki Mogi et al. · 2025 · Hypertension Research
  65. Effect of Baseline Antihypertensive Treatments on Stroke Severity and Outcomes in the BP TARGET Trial
    Benjamin Maïer, Benjamin Gory, Bertrand Lapergue, Igor Sibon, Sébastien Richard, Maeva Kyheng, Julien Labreuche, Jean‐Philippe Désilles, Raphaël Blanc, Michel Piotin et al. · 2022 · Stroke
  66. Sodium chloride-induced changes in oxidative stress, inflammation, and dysbiosis in experimental multiple sclerosis
    Francisco A. Martín-Hersog, Ana Muñoz-Jurado, Begoña M. Escribano, Evelio Luque, Alberto Galván, Manuel LaTorre, Ana I. Giraldo, Javier Caballero‐Villarraso, Eduardo Agüera, Abel Santamarı́a et al. · 2022 · Nutritional Neuroscience
  67. Candesartan protects against unilateral peripheral limb ischemia in type-2 diabetic rats: Possible contribution of PI3K-Akt-eNOS-VEGF angiogenic signaling pathway
    Shimaa S. Khaled, Rania Ramadan Abdelaziz, Ghada Mohamed Suddek, Sally L. Elshaer · 2023 · International Immunopharmacology
  68. Telmisartan is neuroprotective in a hiPSC-derived spinal microtissue model for C9orf72 ALS via inhibition of neuroinflammation
    Berkiye Sonustun, Björn Friedhelm Vahsen, Mario Ledesma-Terrón, Zhuoning Li, Laura Tuffery, Nan Xu, Elizabeth L. Calder, Johannes Jungverdorben, Leslie Weber, Aaron Zhong et al. · 2025 · Stem Cell Reports
  69. Curcuma Longa Methanolic Extract and Losartan Improves Memory Impairment and Oxidative Stress induced by a High Caloric Diet in Wistar Rats
    Sara Brikat, Mouloud Lamtai, Miloud Chakit, Laila Ibouzine‐Dine, Ilhame Fitah, Oumaima Abouyaala, Abdelhalem Mesfioui, Aboubaker El Hessni · 2024 · Advances in Animal and Veterinary Sciences
  70. Chronic unilateral chemosis following the use of amlodipine besylate
    Kyeong Hwan Kim, Wan Soo Kim · 2014 · BMC Ophthalmology
  71. Visual evoked potentials in women with and without preeclampsia during pregnancy and postpartum
    Ingrid A. Brussé, Caroline B. van den Berg, Johannes J. Duvekot, Marilyn J. Cipolla, Eric A.P. Steegers, Gerhard H. Visser · 2017 · Journal of Hypertension
  72. Inflammation and the Brain Disorders: A Review
    Rahimeh Bargi, Hossein Salmani, Fereshteh Asgharzadeh Yazdi, Mahmoud Hosseini · 2017 · The Neuroscience Journal of Shefaye Khatam
  73. Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT
    Patrick G. Kehoe, Nicholas L Turner, Beth Howden, Lina Jarutyt, Shona Clegg, Ian B. Malone, Josephine Barnes, Casper F. Nielsen, Carole H. Sudre, Aileen Wilson et al. · 2021 · Efficacy and Mechanism Evaluation
  74. Effect of safranal or candesartan on 3-nitropropionicacid-induced biochemical, behavioral and histological alterations in a rat model of Huntington’s disease
    Nagwa Ibrahim Shehata, Dina Mohamed Abd EL-Salam, Roqaya Mahmoud Hussein, Sherine Maher Rizk · 2023 · PLoS ONE
  75. Has bioscience reconciled mind and body?
    Carmel Davies, Catherine Redmond, Sinead O Toole, Barbara Coughlan · 2015 · Journal of Clinical Nursing
  76. Effects of free access to sugar solutions on the control of energy intake
    Changhui Zhao, Thomas W. Castonguay · 2016 · Food Reviews International
  77. Losartan Reverses Hippocampal Increase of Kynurenic Acid in Type 1 Diabetic Rats: A Novel Procognitive Aspect of Sartan Action
    Iwona Chmiel-Perzyńska, Adam Perzyński, Bartosz Olajossy, Paulina Gil-Kulik, Janusz Kocki, Ewa M. Urbańska · 2019 · Journal of Diabetes Research
  78. THE EFFECTS NEUROPROTECTION OF TELMISARTAN ON STROKE WITH HYPERTENSION
    Iin Ernawati, Hanik Badriyah Hidayati, Sumarno Sumarno · 2020 · MNJ (Malang Neurology Journal)
  79. Discovery of therapeutic targets for spinal cord injury based on molecular mechanisms of axon regeneration after conditioning lesion
    Xiaoxiong Wang, Wenxiang Li, Jianping Zhang, Jinze Li, Xianjin Zhang, Min Wang, Zhijian Wei, Shiqing Feng · 2023 · Journal of Translational Medicine
  80. Sex-dependent effects of angiotensin II type 1 receptor blocker on molecular and behavioral changes induced by single prolonged stress
    Emily Ortiz-Nazario, Carla M. Denton-Ortiz, Lawry D.M. Soto-Escobar, Zaira Mateo-Mayol, María Colón-Romero, Anixa Hernández, James T. Porter · 2023 · Behavioural Brain Research
  81. The protective effect of angiotensin II type I receptor blocker (valsartan) on behavioral impairment, NLRP3 , BDNF , and oxidative stress in the brain tissue of ovariectomized female rats
    Salih Erdem, Hale SAYAN ÖZAÇMAK, İnci TURAN, Meryem ERGENÇ · 2024 · Physiological Reports
  82. A review of clinically significant drug-drug interactions involving angiotensin II receptor antagonists and antiepileptic drugs
    Marta Rusek, Stanisław Jerzy Czuczwar · 2020 · Expert Opinion on Drug Metabolism & Toxicology
  83. Association between angiotensin receptor blockers and suicide: nationwide population-based propensity score matching study
    Shih-Yi Lin, Cheng‐Li Lin, Cheng‐Chieh Lin, Wu‐Huei Hsu, Chia‐Der Lin, I‐Kuan Wang, Ming-Han Hsieh, Chung Y. Hsu, Chia‐Hung Kao · 2020 · Journal of Affective Disorders
  84. Experimental Evidences Supporting Training-Induced Benefits in Spontaneously Hypertensive Rats
    Gustavo Santos Masson, Lisete Compagno Michelini · 2017 · Advances in experimental medicine and biology
  85. New Users of Angiotensin II Receptor Blocker–Versus Angiotensin‐Converting Enzyme Inhibitor–Based Antihypertensive Medication Regimens and Cardiovascular Disease Events: A Secondary Analysis of ACCORD‐BP and SPRINT
    Jordan B. King, Ransmond O. Berchie, Catherine G. Derington, Zachary A. Marcum, Daniel O. Scharfstein, Tom Greene, Jennifer S. Herrick, Joshua A. Jacobs, Alexander R. Zheutlin, Adam Phillip Bress et al. · 2023 · Journal of the American Heart Association
  86. Synthesis and biological evaluation of XB-1 analogues as novel histamine H3 receptor antagonists and neuroprotective agents
    Xiaofeng Bao, Yanyan Jin, Xiaolu Liu, Hong Liao, Luyong Zhang, Tao Pang · 2014 · RSC Advances
  87. Contrasting Roles of Ang II and ACEA in the Regulation of IL10 and IL1β Gene Expression in Primary SHR Astroglial Cultures
    Dhanush Haspula, Michelle Alexa Clark · 2021 · Molecules
  88. Effect of amlodipine besylate combined with acupoint application of traditional Chinese medicine nursing on the treatment of renal failure and hypertension by the PI3K/AKT pathway
    Liping Feng, Jiahang Su, Rongxiang Chi, Qiao Zhu, Shuguang Lv, Wenjing Liang · 2019 · International Journal of Molecular Medicine
  89. Transgenic mouse models of sodium and potassium channelopathies in epilepsy: insights into disease mechanisms and therapeutics
    Michael F. Hammer · 2025 · Bioscience Reports
  90. New Paradigm in Cell Therapy Using Sperm Head to Restore Brain Function and Structure in Animal Model of Alzheimer’s Disease: Support for Boosting Constructive Inflammation vs. Anti-Inflammatory Approach
    Nafiseh Pakravan, Ardeshir Abbasi, Zuhair Mohammad Hassan · 2022 · Journal of Immunology Research
  91. Associations among Angiotensin-Converting Enzyme, Neuroinflammation, and Cerebrospinal Fluid Biomarkers of Alzheimer's Disease in Non-Dementia Adults
    Lan-Yang Wang, Hao Hu, Ze-Hu Sheng, Ya‐Nan Ou, Ya‐Nan Ou, Fan Guo, Yang-Ke Zhu, Lan Tan, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Neurotoxicity Research
  92. Subventricular Zone Under the Neuroinflammatory Stress and Parkinson’s Disease
    Keiji Mori, Yoko S. Kaneko, Akira Nakashima, Hiroshi Nagasaki, Toshiharu Nagatsu, Ikuko Nagatsu, Akira Ota · 2011 · Cellular and Molecular Neurobiology
  93. Neuroprotective effects of candesartan in 3-nitropropionic acid-induced Huntington’s disease: modulation of angiotensin and CREB/BDNF/PGC1-α signaling
    Ali M. Elgindy, Ahmed M. Atwa, El‐Sayed El‐Awady, Norhan Mohamed El-Sayed, Naglaa F. El-Orabi · 2025 · Inflammopharmacology
  94. Ang II-mediated effects on BBB integrity in psychiatric and neurological disorders
    Dominique Hyacinthe Hatho Towo, Imad Jari, Coraline Canivet, Jessica Deslauriers · 2026 · Progress in Neuro-Psychopharmacology and Biological Psychiatry
  95. Telmisartan Reduces LPS-Mediated Inflammation and Induces Autophagy of Microglia
    Kwame Ofori Affram, Zachary C. Janatpour, Nagesh C. Shanbhag, Sonia Villapol, Aviva J. Symes · 2024 · Neuroglia
  96. Long-term treatment with haloperidol modulates angiotensin I-converting enzyme (ACE) activity in transgenic animal model with construct validity for schizophrenia studies
    William Y. Oyadomari, Thays Calista Santiago, Leonardo Basso, Vitor Oliveira, Fabio Cardoso Cruz, João Victor Silva Nani, Mirian A.F. Hayashi · 2025 · Brain Research
  97. Reactive Oxygen Species and Cerebrovascular Diseases
    Alyson A. Miller, T. Michael De Silva, Grant Raymond Drummond, Christopher Graeme Sobey, Sophocles Chrissobolis · 2014 · Springer eBooks
  98. EFFECT OF COMBINATION TREATMENT OF CANDESARTAN AND CURCUMIN ON TRAUMATIC BRAIN INJURY IN MICE
    Sarah A. Baraka · 2018 · Al-Azhar Journal of Pharmaceutical Sciences/Al-Azhar Journal of Pharmaceutical Sciences
  99. Clinical Trials of Anti-Inflammatory Treatments of Major Depression
    Norbert Müller · 2018 · Elsevier eBooks
  100. Neurobiological Principles: Psycho-Neuro-Immuno-Endocrinology
    Norbert Müller · 2020 · Springer eBooks